FeesSafety
Pluang+

Palvella launches QTORIN™ docetaxel for rare skin cancer EMPD, aiming for first FDA-approved topical therapy.

Market News
19 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Palvella launches QTORIN™ docetaxel for rare skin cancer EMPD, aiming for first FDA-approved topical therapy.

Palvella Therapeutics announced QTORIN™ docetaxel, a new topical treatment candidate for Extramammary Paget’s Disease (EMPD), a rare and serious genital and perianal skin cancer affecting over 10,000 U.S. patients. This program aims to shift EMPD treatment from invasive surgeries to a localized topical therapy, potentially becoming the first FDA-approved treatment for the disease. Palvella has started regulatory preparations and plans to begin a Phase 2 clinical trial after FDA discussions in 2027. This development highlights Palvella's focus on rare skin diseases with no current FDA-approved therapies.

Palvella Therapeutics' new QTORIN™ docetaxel program for Extramammary Paget’s Disease provides context for health-sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 19, 2026 19:13 WIB: Among 150 priced US health-sector stocks, 82 rose and 63 fell. RXRX traded at USD 2.91 with a 3.01% gain and a buy-heavy order split of 63%, while ELAN and ERAS saw gains of 2.92% and 2.76% at USD 27.48 and USD 14.14 respectively, with typical hold times ranging from 4 to 23 days.

More News

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works reported third-quarter earnings per share of $0.26, surpassing the $0.12 estimate, and revenue of $1.58 billion, above the $1.55 billion estimate. The company also announced a new $500 million share repurchase program and raised its...

Company Fundamentals
Bullish
52 minutes ago
Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal has integrated its neutral-atom quantum processors natively into Slurm's Hierarchical Resources (HRES) system, recently expanded by NVIDIA. This allows supercomputing centers to manage quantum processing units (QPUs) alongside CPUs and GPUs mo...

Market News
Bullish
56 minutes ago
SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX currently earns most of its profits from its Starlink satellite internet service, which has 13.6 million subscribers and generated $2.37 billion in operating income last quarter. However, the company is aggressively pivoting towards artificial...

Market News
Bullish
1 hour ago
TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

Despite a recent 25% drop in semiconductor stocks, TSMC and Applied Materials stand out due to their dominant market positions and growth potential. TSMC leads with a 73% share in the foundry market, benefiting from AI chip demand and planned price h...

Market News
Bullish
1 hour ago
Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

The stock market is vulnerable to a sharp correction due to rising interest rates and uncertainty in the AI industry following Nvidia CEO Jensen Huang's departure amid scandal. Inflation pressures have led the Federal Reserve to raise rates, potentia...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App